Actuate Therapeutics ACTU
NASDAQ ACTU
$0.62 +0.02 (+2.85%)
At close: Oct 20, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) EBT (2023 - 2026)

Updated

Actuate Therapeutics' EBT was -$4.87 million in Q2 2026, compared with -$5.95 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) EBT (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Actuate Therapeutics' EBT was -$20.78 million through Jun 30, 2026; for FY2025, it came in at -$22.23 million.

  • In earlier years, EBT was -$24.96 million in FY2024 and -$24.66 million in FY2023.
  • Quarterly EBT has moved between -$7.76 million (Q1 2024) and -$4.55 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 6.75 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 4.28 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 2.80 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -10.25 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -653.00 Mn
10 Actuate Therapeutics 14.74 Mn -26.26 Mn - -4.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.87 Mn
Dec 31, 2025 -4.55 Mn
Sep 30, 2025 -5.41 Mn
Jun 30, 2025 -5.95 Mn
Mar 31, 2025 -6.32 Mn
Dec 31, 2024 -6.45 Mn
Sep 30, 2024 -5.32 Mn
Jun 30, 2024 -5.43 Mn
Mar 31, 2024 -7.76 Mn
Dec 31, 2023 -7.56 Mn
Sep 30, 2023 -6.35 Mn
Jun 30, 2023 -5.59 Mn
API Access

Actuate Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ACTU&period=max&api_key=YOUR_API_KEY